Posted on 2 Comments

FDA Approves Aducanumab the first new treatment for Alzheimer’s disease in nearly 20 years

external content.duckduckgo 11

the staff of the Ridgewood blog

Ridgewood NJ, Aducanumab is the first new treatment for Alzheimer’s disease that has been approved for use in the US in nearly 20 years. It targets the underlying cause of the disease rather than its symptoms. While it is not a miracle drug, its approval will be a huge boost to dementia research. Alzheimer’s disease affects more than 30 million people around the world, most over the age of 65.

Continue reading FDA Approves Aducanumab the first new treatment for Alzheimer’s disease in nearly 20 years

Posted on Leave a comment

Essential Details to Keep In Mind before Importing and Selling Medical Devices

external content.duckduckgo

In a bid to improve the health sector, most governments and private parties import medical devices. However, it is not a “one call settles it all” kind of scenario. Depending on factors such as the prevailing market, international relations, foreign trade policies, your home country’s GDP, and the current regulations, the entire process can be a bit overwhelming.

Continue reading Essential Details to Keep In Mind before Importing and Selling Medical Devices

Posted on 4 Comments

What to Do If You Have Already Received the J&J/Janssen COVID-19 Vaccine

external content.duckduckgo 68

the staff of the Ridgewood blog

Ridgewood NJ, on April 13, 2021, CDC and FDA recommended a pause in the use of Johnson & Johnson’s Janssen COVID-19 Vaccine. Of the nearly 7 million doses administered so far in the United States, a small number of reports of a rare and severe type of blood clot have been reported in people after receiving the J&J/Janssen COVID-19 Vaccine.  All reports occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination. As of April 13, 2021, of the more than 180 million doses administered so far of the Pfizer-BioNTech or Moderna vaccines, no reports matching those associated with the J&J/Janssen vaccine have been received.

Continue reading What to Do If You Have Already Received the J&J/Janssen COVID-19 Vaccine

Posted on Leave a comment

Valley Hospital statement on the FDA and CDC request to “pause” the use of the Johnson & Johnson vaccine

173437231 5503166259723598 7722685997773307412 n

the staff of the Ridgewood blog

Ridgewood NJ, the Valley Hospital issued the following statement on the FDA and CDC request to “pause” the use of the Johnson & Johnson vaccine :

Continue reading Valley Hospital statement on the FDA and CDC request to “pause” the use of the Johnson & Johnson vaccine

Posted on 6 Comments

CDC is recommending a “pause” in the administration of the single-dose Johnson & Johnson COVID-19 vaccine

external content.duckduckgo 68

the staff of the Ridgewood blog

New Brunswick NJ, the CDC is recommending a “pause” in the administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating clots in six women that occurred 6 to 13 days after vaccination. The clots were observed in the sinuses of the brain along with reduced platelet counts — making the usual treatment for blood clots, the blood thinner heparin, potentially “dangerous.”

Continue reading CDC is recommending a “pause” in the administration of the single-dose Johnson & Johnson COVID-19 vaccine

Posted on Leave a comment

US National Institute of Allergy and Infectious Diseases Questions AstraZeneca COVID vaccine’s Efficacy Estimate

AstraZeneca Oxford vaccine 900x506 1
the staff of the Ridgewood blog
Ridgewood NJ, according to Johns Hopkins Center for Health Security, AstraZeneca announced preliminary results from a Phase 3 clinical trial for its SARS-CoV-2 vaccine, developed in collaboration with the University of Oxford. The trial included more than 32,000 participants in Chile, Peru, and the US, including 21,583 who received at least one dose of the vaccine. The press release reports an overall efficacy of 79% against any COVID-19 disease among all age groups and 80% efficacy for adults aged 65 years and older. Additionally, the press release describes 100% efficacy against severe disease and hospitalization. AstraZeneca explicitly noted that an independent review of the safety data “found no increased risk of thrombosis or events characterized by thrombosis” associated with the vaccine. Previous analysis of data from trials in Brazil, South Africa, and the UK estimated the overall efficacy to be 60%.

Continue reading US National Institute of Allergy and Infectious Diseases Questions AstraZeneca COVID vaccine’s Efficacy Estimate

Posted on 1 Comment

Johnson & Johnson single-shot COVID-19 vaccine Gets the Green Light from FDA

external content.duckduckgo 68

the staff of the Ridgewood blog

New Brunswick NJ, Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older.

Continue reading Johnson & Johnson single-shot COVID-19 vaccine Gets the Green Light from FDA

Posted on 1 Comment

Johnson & Johnson Single-Shot COVID-19 Vaccine Unanimously Recommended for Emergency Use Authorization by FDA Advisory Committee

external content.duckduckgo 61

the staff of the Ridgewood blog

New Brunswick NJ, Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend Emergency Use Authorization (EUA) for the Company’s single-shot COVID-19 vaccine candidate for adults 18 and older, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. The vote was based on a totality of scientific evidence provided by the Company, including efficacy and safety data from the Phase 3 ENSEMBLE trial.

Continue reading Johnson & Johnson Single-Shot COVID-19 Vaccine Unanimously Recommended for Emergency Use Authorization by FDA Advisory Committee

Posted on Leave a comment

FDA Confirms Johnson & Johnson’s one-shot COVID-19 Vaccine Safety

external content.duckduckgo 61

the staff of the Ridgewood blog

New Brunswick NJ, U.S. Food and Drug Administration (FDA) staff said in documents published on Wednesday, that  Johnson & Johnson’s one-shot COVID-19 vaccine appeared safe and effective in trials, paving the way for its approval for emergency use (EUA) .

Continue reading FDA Confirms Johnson & Johnson’s one-shot COVID-19 Vaccine Safety

Posted on Leave a comment

Game Changer : Pfizer and BioNTech asks the FDA to allow their Covid-19 shot to be stored at normal pharmaceutical freezers

external content.duckduckgo 51

the staff of the Ridgewood blog

Ridgewood NJ, In a potential game changer for vaccine distribution, Pfizer and BioNTech asked the U.S. Food and Drug Administration to allow their Covid-19 shot to be stored at temperatures found in normal pharmaceutical freezers. Up until now, the doses had to be stored in super-cold specialty freezers, complicating distribution.

Continue reading Game Changer : Pfizer and BioNTech asks the FDA to allow their Covid-19 shot to be stored at normal pharmaceutical freezers

Posted on 2 Comments

Johnson & Johnson’s One-shot Covid Vaccine is Safe and Generates Promising Immune Response in Early Trials

64310182 10156106202320951 9163112232647655424 n

the staff of the Ridgewood blog

New Brunswick NJ, Interim Phase 1/2a data were published today in the New England Journal of Medicine demonstrating that the Company’s single-dose investigational COVID-19 vaccine candidate (JNJ-78436735) – being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson – provided an immune response that lasted for at least 71 days, the duration of time measured in this study in participants aged 18-55 years. A preview of part of these interim data was posted on medRxiv in September 2020.

Continue reading Johnson & Johnson’s One-shot Covid Vaccine is Safe and Generates Promising Immune Response in Early Trials

Posted on Leave a comment

Ohio State University Researchers Develop Artificial Intelligence to Speed Up Drug and Vaccine Approval Process

AdobeStock 90603827 scaled 1

the staff of the Ridgewood blog

Ridgewood NJ, Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed.

Continue reading Ohio State University Researchers Develop Artificial Intelligence to Speed Up Drug and Vaccine Approval Process

Posted on 1 Comment

FDA Advisory Committee Votes To Endorse Emergency Use for Moderna’s COVID-19 Vaccine

c9215d4f 47bf 4fbe ad5a 570047c8daf0

the staff of the Ridgewood blog

CAMBRIDGE, Mass. Moderna, Inc., (Nasdaq:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today confirmed that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended that the FDA grant an Emergency Use Authorization (EUA) for the Company’s COVID-19 vaccine candidate, mRNA-1273. 20 VRBPAC members recommended for EUA, 0 members voted against, and 1 abstained.

Continue reading FDA Advisory Committee Votes To Endorse Emergency Use for Moderna’s COVID-19 Vaccine

Posted on Leave a comment

Hackensack Meridian Health : Behind the COVID-19 Vaccine Approval Process

Moderna2

Clinical Contributors to this Story  Ihor Sawczuk, M.D. contributes to topics such as Medical Research, Urology.

Hackensack NJ, The United States has begun to roll out COVID-19 vaccines in an effort to help stop the pandemic. Millions of people will line up across the country to get the vaccine, expected to be approved by the U.S. government.

For many, we’ve never really thought about the approval process that every vaccine, including the COVID-19 vaccine, must go through before getting approved for public use. It’s an extensive and rigorous process to ensure it’s safe before it can be distributed to the community.

Continue reading Hackensack Meridian Health : Behind the COVID-19 Vaccine Approval Process

Posted on Leave a comment

How CBD and THC Can Improve Your Life

cbd oil on amazon theres no such thing

In modern times, it seems everyone has an understanding of what is good for their body. Eating healthy, constantly staying active, and taking natural supplements helps boost the immune and circulatory system but very few people take into consideration their mental health. 

Continue reading How CBD and THC Can Improve Your Life